Regional
Confederated Tribes of Grand Ronde Department of Emergency Services
Drugs and doses50
A–C Acetaminophen, Activated Charcoal, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Buprenorphine, Calcium Gluconate9
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1000 mg | IV | not captured | standing | pages 58, 94 |
| Mild to moderate pain | adult | 650–1000 mg | PO | not captured | standing | pages 58, 94 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | pages 58, 94 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g/kg | PO | not captured | standing | pages 73, 95 |
| Other | peds | 1 g/kg | PO | not captured | standing | pages 73, 95 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV | not captured | standing | pages 45, 46, 96 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | pages 45, 46, 96 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 78, 97 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | pages 78, 97 |
| Hyperkalemia | peds | 2.5–10 mg | NEB | not captured | standing | pages 59, 97 |
| Other | adult | 2.5 mg | NEB | not captured | standing | pages 74, 97 |
| Other | peds | 2.5 mg | NEB | not captured | standing | pages 74, 97 |
| Other | peds | 2.5 mg | NEB | not captured | standing | page 80 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV/IO | not captured | standing | pages 48, 49, 98, 99 |
| Other | adult | 150 mg | IV/IO | not captured | standing | pages 45, 98 |
| Other | adult | 150 mg | IV/IO | not captured | standing | pages 41, 98 |
| Other | adult | 150 mg | IV/IO | not captured | standing | pages 51, 98 |
| Other | peds | 2.5 mg/kg | IV/IO | not captured | standing | pages 48, 49, 98, 99 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 38, 98, 99 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 38, 98, 99 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 324 mg | PO | not captured | standing | pages 51, 100 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | pages 42, 101, 102 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 42, 101, 102 |
| Other | adult | 0.5 mg | IV/IO | not captured | standing | pages 101, 102, 165 |
| Other | adult | 1–2 mg | IV/IO/IM | not captured | standing | pages 74, 101, 102 |
| Other | adult | 3–5 mg | IV/IO/IM | not captured | standing | pages 74, 101, 102 |
| Other | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 101, 102, 165 |
| Other | peds | 0.05 mg/kg | IV/IO/IM | not captured | standing | pages 74, 101, 102 |
| Other | peds | 0.05 mg/kg | IV/IO/IM | not captured | standing | pages 74, 101, 102 |
Buprenorphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 16 mg | SL | not captured | standing | page 103 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1–3 g | IV/IO | not captured | standing | page 104 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.6 mL/kg | IV/IO | not captured | standing | page 104 |
| Burns | adult | 3 g | TOP | not captured | standing | page 104 |
| Hyperkalemia | adult | 3 g | IV/IO | not captured | standing | pages 59, 104 |
| Hyperkalemia | adult | 3 g | IV/IO | not captured | standing | pages 38, 104 |
| Hyperkalemia | peds | 0.6 mL/kg | IV/IO | not captured | standing | pages 59, 104 |
D–F Dexamethasone, Dextrose, Diltiazem, Diphenhydramine, Dopamine, Droperidol, Epinephrine, Etomidate, Fentanyl, Furosemide10
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 10 mg | IV/IO/IM/PO | not captured | standing | page 105 |
| Anaphylaxis | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 105 |
| Croup | adult | 10 mg | IV/IO/IM/PO | not captured | standing | page 105 |
| Croup | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 105 |
| Other | adult | 10 mg | IV/IO/IM/PO | not captured | standing | page 105 |
| Other | adult | 10 mg | IV/IO/IM/PO | not captured | standing | page 105 |
| Other | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 105 |
| Other | peds | 10 mg | IV/IO/IM/PO | not captured | standing | page 105 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 10–25 g | IV/IO | not captured | standing | page 106 |
| Hypoglycemia | peds | 5 mL/kg | IV/IO | not captured | standing | page 106 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 10 mg | IV | not captured | standing | page 107 |
| Atrial fibrillation with RVR | adult | 10 mg | IV | not captured | standing | page 107 |
| SVT | adult | 10 mg | IV | not captured | standing | page 107 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 1 mg/kg | IV/IM | not captured | standing | page 108 |
| Allergic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 108 |
| Anaphylaxis | adult | 1 mg/kg | IV/IM | not captured | standing | page 108 |
| Anaphylaxis | peds | 1 mg/kg | IV/IM | not captured | standing | page 108 |
| Dystonic reaction | adult | 1 mg/kg | IV/IM | not captured | standing | page 108 |
| Dystonic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 108 |
| Procedural sedation | peds | 1 mg/kg | IV/IM | not captured | standing | page 108 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 2–10 mcg/kg | IV | not captured | standing | page 109 |
| Bradycardia | peds | 2–10 mcg/kg | IV | not captured | standing | page 109 |
| Cardiogenic shock | adult | 5–20 mcg/kg | IV | not captured | standing | page 109 |
| Cardiogenic shock | peds | 5–20 mcg/kg | IV | not captured | standing | page 109 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 0.625 mg | IV | not captured | standing | pages 110, 111 |
| Procedural sedation | adult | 2.5–5 mg | IV/IO/IM | not captured | standing | page 111 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 111 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | pages 31, 32, 112 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 31, 32, 112 |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IM | not captured | standing | pages 78, 112 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | pages 78, 112 |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | pages 42, 43, 112 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 42, 43, 112 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 38, 112 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 38, 112 |
| Croup | peds | 5 mg | NEB | not captured | standing | pages 80, 112, 113 |
| Hypotension / shock | adult | 10–20 mcg | IV/IO | not captured | standing | page 113 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 0.15 mg/kg | IV/IO | not captured | standing | page 114 |
| Procedural sedation | peds | 0.15 mg/kg | IV/IO | not captured | standing | page 114 |
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 114 |
| RSI induction | peds | 0.3 mg/kg | IV/IO | not captured | standing | page 114 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 50 mcg | IV/IO | not captured | standing | pages 37, 116 |
| Cardiac arrest | peds | 50 mcg | IV/IO | not captured | standing | pages 37, 116 |
| Mild to moderate pain | adult | 50–100 mcg | IV/IN | not captured | standing | pages 70, 71, 115, 116 |
| Mild to moderate pain | adult | 50–100 mcg | IM | not captured | standing | pages 70, 71, 115, 116 |
| Mild to moderate pain | peds | 1–2 mcg/kg | IM | not captured | standing | pages 70, 71, 115, 116 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IN | not captured | standing | pages 70, 71, 115, 116 |
| Post-intubation sedation | adult | 50–100 mcg | IV/IO | not captured | standing | page 116 |
| Post-intubation sedation | peds | 1 mcg/kg | IV/IO | not captured | standing | page 116 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 20 mg | IV | not captured | standing | page 117 |
G–L Glucagon, Haloperidol, Hydromorphone, Hydroxocobalamin, Ibuprofen, Ipratropium, Ketamine, Ketorolac, Labetalol, Lidocaine, Lorazepam11
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | pages 29, 30, 55, 118 |
| Other | adult | 1 mg | IV/IM | not captured | standing | pages 31, 118 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 1.25 mg | IV/IM | not captured | standing | pages 64, 121, 231 |
| Procedural sedation | adult | 5–10 mg | IV/IO/IM | not captured | standing | pages 24, 25, 26, 120, 121 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.25–0.5 mg | IV | not captured | standing | pages 70, 122, 123, 231 |
| Mild to moderate pain | adult | 0.5–1 mg | IM | not captured | standing | pages 70, 122, 123, 231 |
| Mild to moderate pain | peds | 0.01 mg/kg | IV | not captured | standing | pages 70, 122, 123, 231 |
| Mild to moderate pain | peds | 0.01 mg/kg | IM | not captured | standing | pages 70, 122, 123, 231 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | pages 34, 73, 74, 124 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | pages 34, 73, 74, 124 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 200–600 mg | PO | not captured | standing | pages 58, 125, 126 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | pages 58, 125, 126 |
| Mild to moderate pain | adult | 200–600 mg | PO | not captured | standing | pages 58, 70, 125, 126 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | pages 58, 70, 125, 126 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | pages 78, 127 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | pages 78, 127 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 12.5–25 mg | IV/IO | not captured | standing | pages 71, 128 |
| Mild to moderate pain | adult | 25–50 mg | IM | not captured | standing | page 128 |
| Mild to moderate pain | peds | 0.3 mg/kg | IV/IO | not captured | standing | pages 71, 128 |
| Post-intubation sedation | adult | 0.5–1 mg/kg | IV/IO | not captured | standing | pages 128, 165 |
| RSI induction | adult | 200 mg | IV/IO | not captured | standing | pages 128, 164 |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | pages 128, 164 |
| Seizure | adult | 1 mg/kg | IV/IO | not captured | standing | page 128 |
| Seizure | adult | 2 mg/kg | IM | not captured | standing | page 128 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | page 129 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 129 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV | not captured | standing | page 129 |
| Mild to moderate pain | peds | 1 mg/kg | IM | not captured | standing | page 129 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV | not captured | standing | page 130 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 131 |
| Other | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 131 |
| Other | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 131 |
| Other | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 131 |
| Mild to moderate pain | adult | 40 mg | IO | not captured | standing | page 131 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | page 131 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.5–1 mg | IV/IM | not captured | standing | page 133 |
| Other | adult | 1–2 mg | IV/IO | not captured | standing | page 133 |
| Other | adult | 1 mg | IV/IO | not captured | standing | page 133 |
| Other | adult | 2 mg | IM | not captured | standing | page 133 |
| Other | peds | 0.05 mg/kg | IV/IO | not captured | standing | page 133 |
| Other | peds | 0.1 mg/kg | IM | not captured | standing | page 133 |
| Post-intubation sedation | adult | 1–2 mg | IV/IO | not captured | standing | pages 132, 133 |
| Post-intubation sedation | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 132, 133 |
| Procedural sedation | adult | 2 mg | IV/IO | not captured | standing | pages 132, 133 |
| Procedural sedation | adult | 2 mg | IM | not captured | standing | pages 132, 133 |
| Procedural sedation | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 132, 133 |
| Procedural sedation | peds | 0.05 mg/kg | IM | not captured | standing | pages 132, 133 |
| Procedural sedation | peds | 0.1 mg/kg | IM | not captured | standing | pages 132, 133 |
| Seizure | adult | 2 mg | IV/IO | not captured | standing | pages 132, 133 |
| Seizure | adult | 4 mg | IM | not captured | standing | pages 132, 133 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 132, 133 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | pages 132, 133 |
M–O Magnesium Sulfate, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Olanzapine, Ondansetron, Oxymetazoline, Oxytocin10
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | page 134 |
| Other | adult | 2 g | IV | not captured | standing | page 134 |
| Other | adult | 4 g | IV/IO | not captured | standing | page 134 |
| Wide-complex tachycardia | adult | 2 g | IV/IO | not captured | standing | page 134 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2.5 mg | IV/IO | not captured | standing | pages 37, 135 |
| Post-intubation sedation | adult | 2.5–5 mg | IV/IO | not captured | standing | pages 135, 136 |
| Post-intubation sedation | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 135, 136 |
| Procedural sedation | adult | 2.5–5 mg | IV/IO | not captured | standing | pages 133, 135, 136 |
| Procedural sedation | adult | 2.5 mg | IV/IO | not captured | standing | pages 133, 135, 136 |
| Procedural sedation | adult | 5 mg | IM | not captured | standing | pages 133, 135, 136 |
| Procedural sedation | adult | 5 mg | IM | not captured | standing | pages 133, 135, 136 |
| Procedural sedation | adult | 5 mg | IM | not captured | standing | pages 135, 136 |
| Procedural sedation | peds | 0.05 mg/kg | IV/IO | not captured | standing | pages 133, 135, 136 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 133, 135, 136 |
| Procedural sedation | peds | 0.1 mg/kg | IM | not captured | standing | pages 133, 135, 136 |
| Procedural sedation | peds | 0.1 mg/kg | IM | not captured | standing | pages 133, 135, 136 |
| Procedural sedation | peds | 0.1 mg/kg | IM | not captured | standing | pages 135, 136 |
| Seizure | adult | 10 mg | IM/IN | not captured | standing | pages 82, 135, 136 |
| Seizure | adult | 5 mg | IV/IO | not captured | standing | pages 82, 135, 136 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 82, 135, 136 |
| Seizure | peds | 0.3 mg/kg | IM/IN | not captured | standing | pages 82, 135, 136 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 2–8 mg | IV | not captured | standing | page 137 |
| Mild to moderate pain | adult | 5–10 mg | IM | not captured | standing | page 137 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV | not captured | standing | page 137 |
| Mild to moderate pain | peds | 0.1 mg/kg | IM | not captured | standing | page 137 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg | IV | not captured | standing | pages 29, 30, 138 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | pages 29, 30, 138 |
| Other | peds | 0.1 mg/kg | IM/IN | not captured | standing | pages 29, 30, 138 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 51, 139 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | pages 77, 139 |
| Other | adult | 0.4 mg | SL | not captured | standing | pages 77, 140 |
| Other | adult | 1 mg | IV | not captured | standing | pages 77, 140 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 4–24 mcg | IV | not captured | standing | page 141 |
| Hypotension / shock | peds | 0.1–0.4 mcg/kg | IV | not captured | standing | page 141 |
Olanzapine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 10 mg | PO | not captured | standing | page 142 |
| Agitation | peds | 2.5–5 mg | PO | not captured | standing | page 142 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IM | not captured | standing | page 143 |
| Nausea / vomiting | adult | 8 mg | PO | not captured | standing | page 143 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 143 |
| Nausea / vomiting | peds | 2–4 mg | PO | not captured | standing | page 143 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 spray | IN | not captured | standing | page 145 |
| Other | peds | 2 spray | IN | not captured | standing | page 145 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IV/IM | not captured | standing | page 146 |
P–R Pralidoxime, Promethazine, Proparacaine, Rocuronium4
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1200 mg | IV/IO | not captured | standing | pages 148, 280 |
| Other | adult | 1800 mg | IV/IO | not captured | standing | pages 148, 280 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5 mg | IV | not captured | standing | pages 64, 147 |
| Nausea / vomiting | adult | 25 mg | IM | not captured | standing | pages 64, 147 |
| Nausea / vomiting | peds | 0.25–1 mg/kg | IV | not captured | standing | pages 64, 147 |
| Nausea / vomiting | peds | 0.25–1 mg/kg | IM | not captured | standing | pages 64, 147 |
Proparacaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Burns | adult | 1 drop | OPH | not captured | standing | pages 57, 149 |
| Burns | peds | 1 drop | OPH | not captured | standing | pages 57, 149 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg/kg | IV/IO | not captured | standing | pages 150, 166 |
| Other | peds | 0.5 mg/kg | IV/IO | not captured | standing | pages 150, 166 |
| RSI induction | adult | 1.2 mg/kg | IV/IO | not captured | standing | pages 150, 164 |
| RSI induction | peds | 1.2 mg/kg | IV/IO | not captured | standing | pages 150, 164 |
S–Z Sodium Bicarbonate, Sodium Thiosulfate, Succinylcholine, Tranexamic Acid, Vecuronium, Ziprasidone6
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 50 mEq | IV/IO | not captured | standing | page 151 |
| Hyperkalemia | adult | 50 mEq | IV/IO | not captured | standing | pages 59, 151 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 74, 151 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 151 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 91, 92, 151 |
| Other | adult | 2.5 mL | NEB | not captured | standing | pages 74, 151 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 74, 151 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | page 151 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 91, 92, 151 |
| Other | peds | 2.5 mL | NEB | not captured | standing | pages 74, 151 |
Sodium Thiosulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 50 mL | IV | not captured | standing | pages 34, 152 |
| Cyanide poisoning | peds | 1.65 mL/kg | IV | not captured | standing | pages 34, 152 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.5 mg/kg | IV/IO | not captured | standing | pages 153, 164 |
| RSI induction | peds | 1.5–2 mg/kg | IV/IO | not captured | standing | pages 153, 164 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Head injury / TBI | adult | 2 g | IV/IO | not captured | standing | pages 91, 154 |
| Obstetric hemorrhage | adult | 2 g | IV/IO | not captured | standing | pages 68, 154 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | pages 85, 154 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 150, 166 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 150, 166 |
| RSI induction | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 150, 166 |
| RSI induction | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 150, 166 |
Ziprasidone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 10–20 mg | IM | not captured | standing | pages 25, 26, 27, 28, 156 |
| Procedural sedation | peds | 10 mg | IM | not captured | standing | pages 25, 26, 27, 28, 156 |
Cite this
Confederated Tribes of Grand Ronde Department of Emergency Services, United States EMS Protocol Census. 216 dose entries, effective 2025-01-06.
https://protoquiz.com/census/agencies/confederated-tribes-of-grand-ronde-department-of-emergency-services/
The census is free and not for sale. Only public agencies are named.